The Genomics Sequencing Center has just upgraded to a new LIMS (Laboratory Information Management System) for its Sanger sequencing platform. For researchers, this means more cost-effective and streamlined best-practice workflows with upgraded tools for data management and distribution. The new system offers a secure web-based environment for real-time tracking of projects and samples, allowing for faster production of quality results. This, in turn, speeds up the publication process for high-impact research being conducted by VT researchers.
As genomic services have become more sophisticated, the demands for LIMS to meet the challenge of modern sequencing have become greater. Since the early LIMS, in which tracking of samples was most important, the modern LIMS has come a long way as software architectures have improved. LIMS now focuses heavily on real-time tracking, processing speed, and data security.
LIMS also helps laboratories enforce standard operating procedures and quality control to provide reliable services to researchers. LIMS can help identify poor samples and keeps them from continuing through the process via integrated quality control. Human error is also less of a factor due to automation.
Services the GSC currently offers in the LIMS are: Sanger Sequencing, Qubit, Covaris, and Tapestation DNA/RNA. The new LIMS includes LabLink, which allows GSC molecular biologists to share and publish results securely to investigators and their collaborators, as well as providing a self-serve portal for project updates. Access to the new LIMS can be found at https://lims.bi.vt.edu/.
LIMS for next-generation sequencing is in development, so researchers can continue to follow the established workflow for our next-gen platforms. For more information, contact Saikumar Karyala.
About the GSC
The Genomics Sequencing Center (GSC) is a dedicated multi-user resource for the development and application of state-of-the-art, Next-Generation Sequencing (NGS) technologies. GSC is a “one-stop shop” providing rapid, cost-effective, and high quality experimental design consultation, and genomic, transcriptomic, and functional-genomics services.
July 30, 2018